Radnor Capital Management LLC lessened its holdings in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 20.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 17,260 shares of the health services provider’s stock after selling 4,415 shares during the period. Radnor Capital Management LLC’s holdings in Maximus were worth $1,288,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently modified their holdings of the company. V Square Quantitative Management LLC bought a new position in Maximus in the 3rd quarter worth approximately $25,000. Eastern Bank purchased a new stake in shares of Maximus during the fourth quarter worth $29,000. GAMMA Investing LLC boosted its holdings in shares of Maximus by 150.6% in the third quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock worth $80,000 after acquiring an additional 518 shares during the period. Quarry LP grew its position in shares of Maximus by 48.0% in the third quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock valued at $95,000 after purchasing an additional 330 shares in the last quarter. Finally, Ariadne Wealth Management LP bought a new stake in shares of Maximus during the 2nd quarter valued at $90,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.
Insider Buying and Selling
In other Maximus news, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the completion of the transaction, the insider now owns 6,567 shares of the company’s stock, valued at $484,841.61. This represents a 25.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Bruce Caswell acquired 3,500 shares of the business’s stock in a transaction dated Tuesday, December 17th. The stock was acquired at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the transaction, the chief executive officer now owns 275,929 shares in the company, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 7,063 shares of company stock worth $502,017 in the last ninety days. 1.40% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on Maximus
Maximus Stock Performance
NYSE:MMS opened at $77.49 on Wednesday. The company has a market capitalization of $4.67 billion, a price-to-earnings ratio of 15.50 and a beta of 0.73. The business has a 50 day moving average of $76.36 and a 200 day moving average of $84.75. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. Maximus, Inc. has a 1-year low of $69.72 and a 1-year high of $93.97.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend is Friday, February 14th. Maximus’s dividend payout ratio is presently 24.00%.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Can Integrated Healthcare Stocks Succeed in Public Markets?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- What Lucid’s Partnership With SoundHound Means for LCID Stock
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.